Medical Device Testing Market Report 2026

The medical device testing market size has grown strongly in recent years. It will grow from $10.46 billion in 2025 to $11.09 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to growth in medical device approvals, increasing regulatory scrutiny, rising adoption of implantable devices, early globalization of medical device manufacturing, demand for standardized quality assurance.

The medical device testing market size is expected to see strong growth in the next few years. It will grow to $14.23 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increase in connected medical devices, rising complexity of class III devices, growing focus on patient safety outcomes, expansion of outsourced testing services, evolving global regulatory frameworks. Major trends in the forecast period include rising demand for comprehensive regulatory compliance testing, growing emphasis on device safety and risk mitigation, expansion of outsourced testing and certification services, increasing focus on cybersecurity and software validation testing, higher adoption of advanced testing for high-risk medical devices.

A rise in medical device recalls is propelling the growth of the medical device testing market. A device recall is a procedure in which the manufacturer or distributor of the device takes corrective measures to remove or rectify issues in the medical device. Medical device testing is utilized by manufacturers to identify potential safety concerns associated with devices and can help determine whether a recall is necessary to ensure patient safety and device effectiveness. It also contributes to enhancing product quality to prevent future recalls. For example, in March 2024, Sedgwick, a UK-based risk management and brand protection company, reported that in 2023 there were 3,306 medical device recalls in Europe (EU + UK), marking a 20% increase compared to 2022. Thus, the rising number of medical device recalls is fueling the growth of the medical device testing market.

Major companies in the medical device testing market are emphasizing innovation in testing and verification, including advanced third-party validation to ensure device safety, usability, and regulatory compliance. Advanced third-party validation involves independent testing carried out by specialized laboratories to verify that devices comply with performance and regulatory standards. For example, in October 2023, UL Solutions, a US-based provider of medical testing, inspection, and certification services, expanded its medical device testing capabilities at its Rochester Hills laboratory. These enhancements include verification and validation, usability testing, cybersecurity assessments, and environmental stress testing, assisting manufacturers in improving device safety, reliability, and regulatory adherence.

In January 2025, NAMSA Inc., a US-based medical research and testing company, acquired the U.S. medical-device testing operations of WuXi AppTec for an undisclosed amount. Through this acquisition, NAMSA intends to strengthen its MedTech testing and clinical research capabilities by integrating WuXi AppTec’s U.S. testing operations, expanding laboratory capacity, enhancing service offerings, and accelerating time-to-market for medical-device clients. WuXi AppTec Co., Ltd., based in China, specializes in contract research, testing, and manufacturing services for pharmaceutical, biotechnology, and medical-device companies.

Major companies operating in the medical device testing market are Intertek Group plc., SGS SA, Bureau Veritas Group, TUV SUD AG, TUV Rheinland Group, Pace Analytical Services LLC., Charles River Laboratories Inc., UL Solutions, North American Science Associates LLC, Medistri SA, WuXi AppTec Inc., Cordant Health Solutions, GE Healthcare Technologies Inc., Thermo Fisher Scientific Inc., Biomedical Device Labs, NSF International, Analytical Lab Group LLC, Boston Analytical, DDL Inc., Element Materials Technology, Empirical Testing Corp., Eurofins Scientific, Gateway Analytical LLC, iuvo BioScience, Laboratory Corporation of America Holdings, Microtest Laboratories Inc., Nelson Laboratories LLC, National Technical Systems Inc., Pacific Biolabs Inc., Sterigenics International LLC, Toxikon Corporation, WCG Imaging, Westpak Inc.

North America was the largest region in the medical device testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the medical testing device market report during the forecast period. The regions covered in the medical device testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical device testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs influence the medical device testing market by increasing costs for imported testing equipment, consumables, and calibration tools. Regions such as asia-pacific, europe, and north america are most affected due to dependence on cross-border supply chains. Elevated tariffs may slow testing timelines and increase service costs. However, they also encourage local testing infrastructure development and strengthen regional compliance capabilities.

The medical device testing market research report is one of a series of new reports that provides medical device testing market statistics, including medical device testing industry global market size, regional shares, competitors with a medical device testing market share, detailed medical device testing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device testing industry. This medical device testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical device testing is the process of assessing and confirming the safety, effectiveness, and quality of medical devices. It ensures that products are safe and effective for patient use and comply with the standards and requirements established by regulatory authorities.

The primary types of medical device testing include physical testing, chemical or biological testing, cybersecurity testing, microbiology and sterility testing, among others. Physical testing subjects medical devices to various tests to assess their performance, durability, and safety, helping manufacturers ensure their products are reliable, safe, and effective. Device classes, including class I, class II, and class III, are sourced both in-house and through outsourcing and offer services such as testing, inspection, and certification. These services are utilized by a range of end-users, including hospitals, research centers, homecare clinics, and more.

The medical devices testing market includes revenues earned by entities by providing services such as biocompatibility testing services, bio-burden determination services, and quality assurance testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.